Your browser doesn't support javascript.
loading
SR 57227A, a serotonin type-3 receptor agonist, as a candidate analgesic agent targeting nociplastic pain.
Nakamura, Yukiko; Sumi, Takuya; Mitani, Osamu; Okamoto, Takashi; Kubo, Erika; Masui, Kuniharu; Kondo, Makoto; Koyama, Yoshihisa; Usui, Noriyoshi; Shimada, Shoichi.
Afiliación
  • Nakamura Y; Department of Novel Diagnosis and Treatment Division, Addiction Research Unit, Osaka Psychiatric Medical Center, Osaka Psychiatric Research Center, 3-1-69, Otemae, Chuo-ku, Osaka, 541-8569, Japan; Department of Neuroscience and Cell Biology, Osaka University Graduate School of Medicine, 2-2, Yamadao
  • Sumi T; Department of Neuroscience and Cell Biology, Osaka University Graduate School of Medicine, 2-2, Yamadaoka, Suita, Osaka, 565-0871, Japan. Electronic address: tsumi@acb.med.osaka-u.ac.jp.
  • Mitani O; Maruishi Pharmaceutical Co., Ltd., Drug Discovery and Research Division, 2-2-18, Imazu-Naka, Tsurumi-ku, Osaka, 538-0042, Japan. Electronic address: osamu_mitani@maruishi-pharm.co.jp.
  • Okamoto T; Maruishi Pharmaceutical Co., Ltd., Drug Discovery and Research Division, 2-2-18, Imazu-Naka, Tsurumi-ku, Osaka, 538-0042, Japan. Electronic address: takashi_okamoto@maruishi-pharm.co.jp.
  • Kubo E; Maruishi Pharmaceutical Co., Ltd., Drug Discovery and Research Division, 2-2-18, Imazu-Naka, Tsurumi-ku, Osaka, 538-0042, Japan. Electronic address: erika_kubo@maruishi-pharm.co.jp.
  • Masui K; Maruishi Pharmaceutical Co., Ltd., Drug Discovery and Research Division, 2-2-18, Imazu-Naka, Tsurumi-ku, Osaka, 538-0042, Japan. Electronic address: kuniharu_masui@maruishi-pharm.co.jp.
  • Kondo M; Department of Novel Diagnosis and Treatment Division, Addiction Research Unit, Osaka Psychiatric Medical Center, Osaka Psychiatric Research Center, 3-1-69, Otemae, Chuo-ku, Osaka, 541-8569, Japan; Department of Anatomy and Neuroscience, Graduate School of Medicine, Osaka Metropolitan University, 1-4
  • Koyama Y; Department of Novel Diagnosis and Treatment Division, Addiction Research Unit, Osaka Psychiatric Medical Center, Osaka Psychiatric Research Center, 3-1-69, Otemae, Chuo-ku, Osaka, 541-8569, Japan; Department of Neuroscience and Cell Biology, Osaka University Graduate School of Medicine, 2-2, Yamadao
  • Usui N; Department of Novel Diagnosis and Treatment Division, Addiction Research Unit, Osaka Psychiatric Medical Center, Osaka Psychiatric Research Center, 3-1-69, Otemae, Chuo-ku, Osaka, 541-8569, Japan; Department of Neuroscience and Cell Biology, Osaka University Graduate School of Medicine, 2-2, Yamadao
  • Shimada S; Department of Novel Diagnosis and Treatment Division, Addiction Research Unit, Osaka Psychiatric Medical Center, Osaka Psychiatric Research Center, 3-1-69, Otemae, Chuo-ku, Osaka, 541-8569, Japan; Department of Neuroscience and Cell Biology, Osaka University Graduate School of Medicine, 2-2, Yamadao
Biochem Biophys Res Commun ; 622: 143-148, 2022 09 24.
Article en En | MEDLINE | ID: mdl-35863088
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Serotonina / Agonistas de Receptores de Serotonina Idioma: En Revista: Biochem Biophys Res Commun Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Serotonina / Agonistas de Receptores de Serotonina Idioma: En Revista: Biochem Biophys Res Commun Año: 2022 Tipo del documento: Article